• Home
  • PGRN Best Practices in Clinical Implementation of PGx

PGRN Best Practices in Clinical Implementation of PGx

  • Fri, May 21, 2021
  • 11:00 AM - 12:00 PM
  • Zoom - Members Only

Disease Specific Pharmacogenetics Implementation
Moderator:
  Ron H.N. van Schaik, PhD

"CYP2C19 Testing in Pst-Myocardial Infarction Patients:
The Shands Experience"

             
Ellen Keeley, MD
Division of Cardiovascular Medicine
University of Florida

"Pharmacogenetics in oncology: preventing adverse events"

Sander Bins, MD, PhD,
AIOS interne
Erasmus Medical College
Netherlands



Copyright © 2020 the Pharmacogenomics Research Network. All Rights Reserved.

Follow us on


Become a Member

PGRN logo
Membership dues are vital to continue the mission and work of the PGRN. Founding Members will be listed on the PGRN website. 
Powered by Wild Apricot Membership Software